Serum leptin levels are associated with tamoxifen-induced hepatic steatosis.

Gunel, N; Coskun, UĞUR; Toruner, FÜSUN; Sancak, B; Yilmaz, E; Cengiz, O; Elbeg, S; Uner, A; Ozkan, SEÇİL

doi:10.1185/030079902125001308

Serum leptin levels are associated with tamoxifen-induced hepatic steatosis.

Gunel N., Coskun U., Toruner F. S., Sancak B., Yilmaz E., Cengiz O., ...Daha Fazla

Current medical research and opinion, cilt.19, sa.1, ss.47-50, 2003 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 19 Sayı: 1
Basım Tarihi: 2003
Doi Numarası: 10.1185/030079902125001308
Dergi Adı: Current medical research and opinion
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.47-50
Gazi Üniversitesi Adresli: Evet

Özet

Purpose: Tamoxifen, used in breast cancer treatment, may induce hepatic steatosis. It has been suggested that leptin, which, has a relationship with body fat stores, may be involved in the pathogenesis of hepatic steatosis. In this study, we compared serum leptin levels in tamoxifen-treated patients with and without hepatic steatosis.